Before being packaged, a representative sample from each batch of dried raw cannabis must be tested for microbiological contaminants and mycotoxins using an AOAC-approved technology using appropriate aseptic techniques.
A dried raw cannabis sample passes the microbiological contaminant test if it meets the following standards for microbial and fungal limits in colony forming units per gram (CFU/g):
Standard | |
Total viable aerobic bacteria | < 105 CFU/g |
Total yeast and mold | < 104 CFU/g |
Total coliforms | < 103 CFU/g |
Bile-tolerant gram-negative bacteria | < 103 CFU/g |
Escherichia coli and salmonella species | Not detected in one gram |
For purposes of the mycotoxin test, a dried raw cannabis sample passes if:
the total of aflatoxin B1, B2, G1, and G2 is less than 20 micrograms per kilogram of substance;
A manufacturer must comply with the requirements in this subpart when a sample fails to meet the standards for microbiological contaminant or mycotoxin testing.
If a sample from a batch of dried raw cannabis fails microbiological contaminant or mycotoxin testing, the manufacturer may attempt to remediate the batch one time and resubmit a batch sample for testing. If a batch of dried raw cannabis fails microbiological contaminant or mycotoxin testing after remediation, the manufacturer may:
use the batch to make a medical cannabis concentrate if the processing method effectively sterilizes the batch, such as a method using a hydrocarbon-based solvent or a carbon dioxide closed loop system, or the processing method selectively removes the mycotoxins from the batch; or
A batch that is remediated in accordance with this subpart must be resampled and tested in accordance with this chapter.
MS s 14.389
46 SR 1011
June 15, 2022
Official Publication of the State of Minnesota
Revisor of Statutes